Dejun Kong

6PUBLICATIONS
16CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Epidemiological methodsInnate immunityRegenerative medicine (incl. stem cells)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 10, 2026
Metronomic Capecitabine Triggers Ferroptosis in Hepatocellular Carcinoma Cells Through Inhibition of TYMS.

|Jul 11, 2025
Enhanced Recovery After Surgery Programs Safely Accelerate Recovery in Emergency Abdominal Surgery: A Randomized Controlled Trial With Multivariable Risk Profiling.

Jianing Lu, Yan Zhuang, Zhenglu Wang

|Jul 04, 2024
Upregulation of TCPTP in Macrophages Is Involved in IL-35 Mediated Attenuation of Experimental Colitis.

Baoren Zhang, Chenglu Sun, Yanglin Zhu

|Sep 01, 2022
Endometrial Regenerative Cell-Derived Exosomes Attenuate Experimental Colitis through Downregulation of Intestine Ferroptosis.

Yanglin Zhu, Hong Qin, Chenglu Sun

|Jan 08, 2021
Clinical Efficacy and Safety of Stem Cell-Based Therapy in Treating Asherman Syndrome: A System Review and Meta-Analysis.

Yiming Zhao, Qifan Luo, Xiao Zhang

|Aug 28, 2020
IL-37 Gene Modification Enhances the Protective Effects of Mesenchymal Stromal Cells on Intestinal Ischemia Reperfusion Injury.

Dejun Kong, Yonghao Hu, Xiang Li

Pageof 1

Frequent Collaborators

4 joint publications

Hao Wang

2 joint publications

Chenglu Sun

2 joint publications

Shaohua Ren

2 joint publications

Hong Zheng